Proteon Pharmaceuticals poised to grow its bacteriophage products for aquaculture
Bacteriophage producer nets €21 million to accelerate the commercialization of its products, which aim to reduce antibiotic usage in aquaculture.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
